Cefzil and Weight decreased - a phase IV clinical study of FDA data

Summary:

Weight decreased is reported as a side effect among people who take Cefzil (cefprozil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Levaquin, and have Hypotension.

The phase IV clinical study analyzes which people have Weight decreased when taking Cefzil. It is created by eHealthMe based on reports of 1,080 people who have side effects when taking Cefzil from the FDA, and is updated regularly.

What is Cefzil?

Cefzil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,106 Cefzil users. Check the latest studies of Cefzil.

What is Weight decreased?

Weight decreased is found to be associated with 3,378 drugs and 4,758 conditions by eHealthMe. Check the latest studies of Weight decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

1,080 people reported to have side effects when taking Cefzil.
Among them, 33 people (3.06%) have Weight decreased.

Among these 33 people:

How long have people been on Cefzil when they have Weight decreased? *

What is the gender of people who have Weight decreased when taking Cefzil? *

female: 93.94 %
male: 6.06 %

What is the age of people who have Weight decreased when taking Cefzil? *

What are other drugs people take besides Cefzil? *

What are other side effects people have besides Weight decreased? *

Nausea And Vomiting: 17 people, 51.52%
Nausea (feeling of having an urge to vomit): 16 people, 48.48%
Abdominal Pain: 14 people, 42.42%
Loss Of Consciousness: 12 people, 36.36%
White Blood Cell Count Increased: 11 people, 33.33%
Skin Ulcer: 11 people, 33.33%
Impaired Healing: 11 people, 33.33%
Hypotension (abnormally low blood pressure): 11 people, 33.33%
Pseudomembranous Colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon): 11 people, 33.33%
Depression: 11 people, 33.33%

What are the existing conditions these people have? *

Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 10 people, 30.30%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 10 people, 30.30%
Hypotension (abnormally low blood pressure): 10 people, 30.30%
Stress And Anxiety: 6 people, 18.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 12.12%
Asthma: 3 people, 9.09%
Tooth Abscess (pus formation in tooth): 2 people, 6.06%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 6.06%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.06%
Osteoporosis (bones weak and more likely to break): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Cefzil and have Weight decreased?

- Check whether Weight decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefzil:

Cefzil (1,106 reports)

Weight decreased treatments and more:

Weight decreased (364,522 reports)

Browse all side effects of Cefzil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight decreased:

Weight decreased (3,378 drugs)

Browse all the conditions that are associated with Weight decreased:

Weight decreased (4,758 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefprozil (the active ingredients of Cefzil) and Cefzil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.